News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
527,833 Results
Type
Article (10101)
Company Profile (177)
Press Release (517555)
Multimedia
Podcasts (4)
Webinars (7)
Section
Business (179987)
Career Advice (370)
Deals (27755)
Drug Delivery (9)
Drug Development (61375)
Employer Resources (24)
FDA (10428)
Job Trends (9406)
News (260939)
Policy (19828)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (578)
Accelerated approval (26)
ADA (19)
Adcomms (1)
Allergies (115)
Alliances (36625)
ALS (132)
Alzheimer's disease (1076)
Antibody-drug conjugate (ADC) (339)
Approvals (11104)
Artificial intelligence (374)
ASCO (194)
Autoimmune disease (236)
Automation (33)
Bankruptcy (270)
Best Places to Work (7604)
BIO (44)
BIOSECURE Act (2)
Biosimilars (154)
Biotechnology (115)
Bladder cancer (148)
Brain cancer (39)
Breast cancer (527)
Cancer (4138)
Cardiovascular disease (252)
Career advice (307)
Career pathing (3)
CAR-T (217)
CDC (2)
Celiac Disease (1)
Cell therapy (560)
Cervical cancer (37)
Clinical research (55756)
Collaboration (1438)
Compensation (1501)
Complete response letters (37)
COVID-19 (937)
CRISPR (64)
C-suite (862)
Cystic fibrosis (94)
Data (6414)
Denatured (4)
Depression (119)
Dermatology (66)
Diabetes (377)
Diagnostics (4278)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (181)
Drug pricing (17)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (77416)
Editorial (4)
Employer branding (3)
Employer resources (23)
Events (95793)
Executive appointments (822)
FDA (13329)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (27)
Funding (1050)
Gene editing (130)
Generative AI (15)
Gene therapy (341)
GLP-1 (397)
Government (1138)
Grass and pollen (3)
Guidances (317)
Healthcare (9892)
Hematology (129)
HIV (51)
Huntington's disease (26)
IgA nephropathy (67)
Immunology and inflammation (126)
Immuno-oncology (69)
Indications (172)
Infectious disease (1149)
Inflammatory bowel disease (153)
Inflation Reduction Act (5)
Influenza (93)
Intellectual property (260)
Interviews (50)
IPO (13511)
IRA (5)
Job creations (2198)
Job search strategy (289)
JPM (3)
Kidney cancer (18)
Labor market (1)
Layoffs (86)
Leadership (2)
Legal (5406)
Liver cancer (50)
Longevity (16)
Lung cancer (609)
Lymphoma (303)
Machine learning (33)
Management (7)
Manufacturing (643)
Marketing (6)
MASH (162)
Medical device (8731)
Medtech (8851)
Mergers & acquisitions (15310)
Metabolic disorders (820)
mRNA (60)
Multiple sclerosis (133)
NASH (7)
Neurodegenerative disease (258)
Neuropsychiatric disorders (50)
Neuroscience (2090)
NextGen: Class of 2026 (3365)
Non-profit (956)
Now hiring (4)
Obesity (258)
Opinion (32)
Ovarian cancer (168)
Pain (187)
Pancreatic cancer (204)
Parkinson's disease (247)
Partnered (11)
Patents (491)
Patient recruitment (592)
Peanut (45)
People (45037)
Pharmaceutical (40)
Pharmacy benefit managers (8)
Phase 1 (17800)
Phase 2 (24950)
Phase 3 (17062)
Pipeline (7598)
Policy (31)
Postmarket research (1708)
Preclinical (7316)
Press Release (41)
Prostate cancer (217)
Psychedelics (8)
Radiopharmaceuticals (244)
Rare diseases (643)
Real estate (3496)
Recruiting (12)
Regulatory (16755)
Reports (18)
Research institute (690)
Resumes & cover letters (49)
Rett syndrome (39)
RNA editing (5)
RSV (48)
Schizophrenia (137)
Series A (175)
Series B (134)
Service/supplier (4)
Sickle cell disease (67)
Spinal muscular atrophy (94)
Sponsored (8)
Startups (2294)
State (1)
Stomach cancer (3)
Supply chain (53)
Tariffs (7)
Vaccines (393)
Venture capital (23)
Weight loss (88)
Women's health (78)
Worklife (1)
Date
Today (62)
Last 7 days (285)
Last 30 days (1314)
Last 365 days (21877)
2026 (12228)
2025 (21850)
2024 (25723)
2023 (29820)
2022 (38095)
2021 (41029)
2020 (36818)
2019 (26116)
2018 (19677)
2017 (21431)
2016 (20439)
2015 (26746)
2014 (23465)
2013 (19516)
2012 (21437)
2011 (21676)
2010 (21477)
Location
Africa (278)
Alabama (80)
Alaska (2)
Arizona (307)
Arkansas (13)
Asia (24780)
Australia (3023)
California (12212)
Canada (3149)
China (1087)
Colorado (479)
Connecticut (441)
Delaware (310)
Europe (40356)
Florida (1821)
Georgia (372)
Hawaii (2)
Idaho (46)
Illinois (729)
India (57)
Indiana (372)
Iowa (14)
Japan (449)
Kansas (103)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1242)
Massachusetts (8314)
Michigan (302)
Minnesota (558)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (12)
Nevada (112)
New Hampshire (64)
New Jersey (2926)
New Mexico (15)
New York (3093)
North Carolina (1404)
North Dakota (4)
Northern California (6141)
Ohio (276)
Oklahoma (18)
Oregon (22)
Pennsylvania (2288)
Puerto Rico (24)
Rhode Island (31)
South America (479)
South Carolina (75)
South Dakota (1)
Southern California (5009)
Tennessee (116)
Texas (1904)
United States (40562)
Utah (356)
Vermont (1)
Virginia (160)
Washington D.C. (41)
Washington State (954)
West Virginia (1)
Wisconsin (82)
527,833 Results for "henlius biopharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alligator Bioscience Comments on Henlius Update on Global Phase 3 Trial with HLX22
June 8, 2026
·
2 min read
Press Releases
Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS® (denosumab injection) and TUZEMTY® (denosumab injection), Biosimilars to PROLIA and XGEVA
June 23, 2026
·
5 min read
Press Releases
Alligator Bioscience Comments on Henlius Update on Long-Term Follow-Up Data for HLX22
May 22, 2026
·
2 min read
Press Releases
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
April 29, 2026
·
8 min read
Press Releases
Alligator Bioscience Comments on Henlius Presentation of HLX49 Preclinical Data at AACR 2026
April 23, 2026
·
2 min read
Press Releases
Alligator Bioscience Comments on Henlius Dosing First Patient in Phase 2/3 Breast Cancer Study of HLX22
March 2, 2026
·
2 min read
Press Releases
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
November 17, 2025
·
19 min read
Press Releases
Forlong Biotechology Announces Collaboration Agreement with Henlius to Develop Innovative Cancer Immunotherapy with an Engineered Cytokine
October 23, 2025
·
4 min read
Press Releases
Illuminare Biotechnologies Appoints Veteran Biopharmaceutical Leader as New CEO
July 14, 2026
·
3 min read
Press Releases
European Commission (EC) Approves Henlius and Organon’s BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively
September 19, 2025
·
9 min read
1 of 52,784
Next
